Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Licensing Deals

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jun 30, 2021 1:05pm

163 Views

Post# 33473760

RE:RE:RE:RE:Licensing Deals

I'm surprised some of the investors here are not interested in seeing a timeline of hemo/thyroid. You're ok with words like coming soon and we are working on it? You wouldn't want a timeline posted on their website that shows what they hope to acheive, when they hope to acheive it and a breakdown of the steps and timelines of each milestone? That was my question that I posted at the AGM and was completely ignored.

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute